4.7 Article

Understanding solid-state processing of pharmaceutical cocrystals via milling: Role of tablet excipients

期刊

出版社

ELSEVIER
DOI: 10.1016/j.ijpharm.2021.120514

关键词

Co-milling; Pharmaceutical cocrystals; Tablet excipients; Solid-state processing; Predictive materials modelling; Molecular informatics

资金

  1. Science Foundation Ireland (SFI) [15/CDA/3491, 12/RC/2275, 13/IA/1980, RC/12/2275]
  2. Government of the Russian Federation [02.A03.21.0011]
  3. Ministry of Science and Higher Education of Russia [FENU-2020-0019]
  4. Science Foundation Ireland (SFI) [13/IA/1980] Funding Source: Science Foundation Ireland (SFI)

向作者/读者索取更多资源

Research on novel cocrystal systems and their physicochemical properties improvement is prevalent, yet the focus on final product formulation is lacking. This study measured the impact of tablet excipients on pharmaceutical cocrystal formulations, supported by Density Functional Theory calculations of intermolecular binding energies. The presence of certain excipients, such as PEG, HPMC, or lactose, was found to yield purer cocrystals during co-milling.
Discovery of novel cocrystal systems and improvement of their physicochemical properties dominates the current literature on cocrystals yet the required end-product formulation is rarely addressed. Drug product manufacturing includes complex API solid state processing steps such as milling, granulation, and tableting. These all require high mechanical stress which can lead to solid-state phase transformations into polymorphs and solvates, or lead to dissociation of cocrystals into their individual components. Here we measured the effect of tablet excipients on solid-state processing of a range of pharmaceutical cocrystal formulations. Our findings were rationalised using Density Functional Theory (DFT) calculations of intermolecular binding energies of cocrystal constituents and co-milling excipients. A 1:1 stoichiometric ratio of API Theophylline (THP) and co-former 4Aminobenzoic acid (4ABA) was co-milled with five different excipients: hydroxypropylmethylcellulose (HPMC), polyvinylpyrrolidone (PVP), polyethylene glycol (PEG), lactose, and microcrystalline cellulose (MCC). The experiments were carried out in 10 and 25 ml milling jars at 30 Hz for different milling times. Co-milled samples were characterised for formation of cocrystals and phase transformation using powder X-ray diffraction (PXRD) and differential scanning calorimetry (DSC). Our data shows that co-milling in the presence of PEG, HMPC or lactose yields purer cocrystals, supported by the calculated stronger excipient interactions for PVP and MCC. We identify a suitably-prepared THP-4ABA pharmaceutical cocrystal formulation that is stable under extended milling conditions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据